Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1996 | 1 |
2009 | 1 |
2022 | 2 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Long-term outcomes in patients with severe aplastic anemia treated with immunosuppression and eltrombopag: a phase 2 study.
Blood. 2022 Jan 6;139(1):34-43. doi: 10.1182/blood.2021012130.
Blood. 2022.
PMID: 34525188
Free PMC article.
Clinical Trial.
Most relapsed patients were retreated with therapeutic doses of CSA +/- EPAG, and two-thirds responded. Clonal evolution to a myeloid malignancy or chromosome 7 abnormality (high-risk) was noted in 5.7% of patients and conferred a poorer overall survival. Nei …
Most relapsed patients were retreated with therapeutic doses of CSA +/- EPAG, and two-thirds responded. Clonal evolution to a myeloid malign …
Prognostic impact of chromosomal changes at relapse after allogeneic hematopoietic cell transplantation for acute myeloid leukemia or myelodysplastic syndrome.
Okada Y, Nakasone H, Nakamura Y, Kawamura M, Kawamura S, Takeshita J, Yoshino N, Misaki Y, Yoshimura K, Matsumi S, Gomyo A, Kawamura T, Akahoshi Y, Kusuda M, Kameda K, Tanihara A, Tamaki M, Kimura SI, Kobayashi S, Kako S, Kimura F, Kanda Y.
Okada Y, et al.
Bone Marrow Transplant. 2022 May;57(5):810-816. doi: 10.1038/s41409-022-01635-4. Epub 2022 Mar 21.
Bone Marrow Transplant. 2022.
PMID: 35314792
Recipients who experience relapse after allogeneic hematopoietic cell transplantation (allo-HCT) often show chromosomal changes between diagnosis and relapse. However, the clinical impact of chromosomal changes and the efficacy of post-relapse treatment according to chromo …
Recipients who experience relapse after allogeneic hematopoietic cell transplantation (allo-HCT) often show chromosomal changes between diag …
Item in Clipboard
The heterogeneous prognosis of patients with myelodysplastic syndrome and chromosome 5 abnormalities: how does it relate to the original lenalidomide experience in MDS?
Kantarjian H, O'Brien S, Ravandi F, Borthakur G, Faderl S, Bueso-Ramos C, Abruzzo L, Pierce S, Shan J, Issa JP, Garcia-Manero G.
Kantarjian H, et al.
Cancer. 2009 Nov 15;115(22):5202-9. doi: 10.1002/cncr.24575.
Cancer. 2009.
PMID: 19691096
Free PMC article.
Considering patients with deletion 5q, the median survival was 33 months with deletion 5q alone, 17 months with deletion 5q and 1 additional abnormality, but only 6 months to 12 months with deletion 5q and > or =2 abnormalities or chromosome 7 abnormality. …
Considering patients with deletion 5q, the median survival was 33 months with deletion 5q alone, 17 months with deletion 5q and 1 additional …
Item in Clipboard
Inheritance of chromosome 7 is associated with a drug-resistant phenotype in somatic cell hybrids.
de Silva M, Kantharidis P, Wall DM, Campbell L, Vrazas V, Nadalin G, Kaczmarczyk SJ, Hu XF, Parkin JD, Zalcberg JR.
de Silva M, et al.
Br J Cancer. 1996 Jan;73(2):169-74. doi: 10.1038/bjc.1996.31.
Br J Cancer. 1996.
PMID: 8546902
Free PMC article.
In this study the inheritance of P-gp expression was examined using hybrids formed after somatic cell fusion between a drug-sensitive human T-cell leukaemia cell line, CEM/CCRF, and a drug-resistant derivative, CEM/A7, which is characterized by a clonal chromosomal duplication du …
In this study the inheritance of P-gp expression was examined using hybrids formed after somatic cell fusion between a drug-sensitive human …
Item in Clipboard
Cite
Cite